Explore the Global Severe Asthma Treatment Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Severe Asthma Treatment Market

Key Insight

Severe asthma treatment sales will rise through 2036, driven by anti-inflammatory drugs at 46.8% of the drug class in 2026. The market was valued at USD 24.32 billion in 2025 and is expected to be worth USD 42.0 billion by 2036, creating an incremental opportunity of USD 16.46 billion.

May 27, 2026

Anurag Sharma

300 Pages

Cite this Report

Severe Asthma Treatment Market

https://www.futuremarketinsights.com/reports/severe-asthma-treatment-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Amgen
BlackRock
Boehringer Ingelheim
Chiesi Farmaceutici S.p.A
GlaxoSmithKline plc (GSK)
Merck KGaA
Mylan (Viatris Inc.)
Novartis
The Vanguard Group
Regeneron Pharmaceuticals
Roche (Genentech)
L'Oréal
Teva Pharmaceuticals

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Severe Asthma Treatment Market

Key Players

Similar Industry Reports